Hyperdiploidy Associated with a High BCR-ABL Transcript Level May Identify Patients at Risk of Progression in Chronic Myeloid Leukemia

Publisher： Karger

E-ISSN： 1421-9662|127|1|7-9

ISSN： 0001-5792

Source： Acta Haematologica, Vol.127, Iss.1, 2011-10, pp. : 7-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combination of EUTOS score and 3‐month BCR‐ABL transcript level identifies a group of good‐risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : E135-E137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

By  

Acta Haematologica, Vol. 120, Iss. 3, 2008-11 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

International Reporting Scale of BCR-ABL1 Fusion Transcript in Chronic Myeloid Leukemia: First Report from India

By  

Acta Haematologica, Vol. 127, Iss. 3, 2012-01 ,pp. : 135-142

Karger

Access to resources Recommend Favorite

Natural History of Southeast Asian Chronic Myeloid Leukemia Patients with Different BCR-ABL Gene Variants

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 114-119

Karger

Access to resources Recommend Favorite

Identifying the Time to Change BCR-ABL Inhibitor Therapy in Patients with Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 130, Iss. 4, 2013-08 ,pp. : 268-278

Karger

Access to resources Recommend Favorite